Literature DB >> 15172498

Assessment of polyglycolic acid mesh and bioactive glass for soft-tissue engineering scaffolds.

Richard M Day1, Aldo R Boccaccini, Sandra Shurey, Judith A Roether, Alastair Forbes, Larry L Hench, Simon M Gabe.   

Abstract

Sufficient neovascularization of neotissue is currently a limiting factor for the engineering of large tissue constructs. 45S5 Bioglass has been investigated extensively in bone tissue engineering but there has been relatively little previous research on its application to soft-tissue engineering. The objectives of this study were to investigate the use of 45S5 Bioglass in soft-tissue engineering scaffolds using in vitro and in vivo models. A fibroblast cell line (208F) was used for in vitro evaluation of surfaces coated with 45S5 Bioglass. Increased proliferation of fibroblasts was observed after growth on polystyrene surfaces coated with low concentrations (0.01-0.2%wt/vol) of 45S5 Bioglass for 24 h in vitro, determined as a change in total cell number by measuring lactate dehydrogenase. At higher concentrations of 45S5 Bioglass and longer periods of incubation (48 and 72 h) on coated surfaces, cell proliferation was reduced. Light microscopy revealed that the morphology of fibroblasts grown on 45S5 Bioglass-coated surfaces was not altered at low concentrations, but at higher concentrations fibroblasts became vacuolated. Enzyme-linked immunosorbent assay of conditioned culture medium collected from fibroblasts grown for 24 h on surfaces coated with low concentrations of 45S5 Bioglass (0.01%wt/vol) was found to contain significantly higher concentrations of vascular endothelial growth factor. Histological examination of polyglycolic acid (PGA)/45S5 Bioglass composite scaffolds that had been implanted subcutaneously into rats revealed that 45S5 Bioglass-coated meshes were well tolerated. Light microscopy revealed that neovascularization into 45S5 Bioglass-coated meshes was significantly increased at 28 and 42 days. Electron microscopy revealed fibroblasts adhering closely to the PGA mesh but not to 45S5 Bioglass particles. The apparent ability of 45S5 Bioglass incorporated into scaffolds to increase neovascularization would be extremely beneficial during the engineering of larger soft-tissue constructs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15172498     DOI: 10.1016/j.biomaterials.2004.01.043

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  49 in total

Review 1.  Bioactive glasses as carriers for bioactive molecules and therapeutic drugs: a review.

Authors:  Jasmin Hum; Aldo R Boccaccini
Journal:  J Mater Sci Mater Med       Date:  2012-02-24       Impact factor: 3.896

Review 2.  The current status of small bowel transplantation in the UK and internationally.

Authors:  S J Middleton; N V Jamieson
Journal:  Gut       Date:  2005-11       Impact factor: 23.059

3.  45S5-Bioglass(®)-based 3D-scaffolds seeded with human adipose tissue-derived stem cells induce in vivo vascularization in the CAM angiogenesis assay.

Authors:  Marina Handel; Timo R Hammer; Patcharakamon Nooeaid; Aldo R Boccaccini; Dirk Hoefer
Journal:  Tissue Eng Part A       Date:  2013-08-12       Impact factor: 3.845

4.  Angiogenic response to bioactive glass promotes bone healing in an irradiated calvarial defect.

Authors:  Ann Leu; Susanne M Stieger; Paul Dayton; Katherine W Ferrara; J Kent Leach
Journal:  Tissue Eng Part A       Date:  2009-04       Impact factor: 3.845

Review 5.  Bone tissue engineering therapeutics: controlled drug delivery in three-dimensional scaffolds.

Authors:  Viviana Mouriño; Aldo R Boccaccini
Journal:  J R Soc Interface       Date:  2009-10-28       Impact factor: 4.118

6.  Effect of nano-sized bioactive glass particles on the angiogenic properties of collagen based composites.

Authors:  Gabriela E Vargas; Luis A Haro Durand; Vanesa Cadena; Marcela Romero; Rosa Vera Mesones; Mirza Mačković; Stefanie Spallek; Erdmann Spiecker; Aldo R Boccaccini; Alejandro A Gorustovich
Journal:  J Mater Sci Mater Med       Date:  2013-02-22       Impact factor: 3.896

7.  45S5 Bioglass(®)-MWCNT composite: processing and bioactivity.

Authors:  Harshit Porwal; Mehdi Estili; Alina Grünewald; Salvatore Grasso; Rainer Detsch; Chunfeng Hu; Yoshio Sakka; Aldo R Boccaccini; Mike J Reece
Journal:  J Mater Sci Mater Med       Date:  2015-06-25       Impact factor: 3.896

8.  An easy-to-use wound dressing gelatin-bioactive nanoparticle gel and its preliminary in vivo study.

Authors:  Chen Wang; Feiyan Zhu; Yang Cui; Huihui Ren; Yue Xie; Ailing Li; Lijun Ji; Xiaozhong Qu; Dong Qiu; Zhenzhong Yang
Journal:  J Mater Sci Mater Med       Date:  2016-12-03       Impact factor: 3.896

9.  Local protective effects of oral 45S5 bioactive glass on gastric ulcers in experimental animals.

Authors:  Ai-niu Ma; Nian Gong; Jin-miao Lu; Jin-lu Huang; Bin Hao; Yang Guo; Jipin Zhong; Yuhong Xu; Jiang Chang; Yong-xiang Wang
Journal:  J Mater Sci Mater Med       Date:  2013-01-18       Impact factor: 3.896

10.  Antibacterial and anticancerous drug loading kinetics for (10-x)CuO-xZnO-20CaO-60SiO2-10P2O5 (2 ≤ x ≤ 8) mesoporous bioactive glasses.

Authors:  Shikha Garg; Swati Thakur; Aayush Gupta; Gurbinder Kaur; Om Prakash Pandey
Journal:  J Mater Sci Mater Med       Date:  2016-12-09       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.